The bill also reauthorizes the FDA to collect user fees from prescription drug and medical device makers, and gives the agency authority to begin collecting user fees for generic drugs.
Next, the Senate will take up the bill and is expected to pass it on to President Obama who will likely sign it into law.
More Articles Related to the FDA:
Consumers Union Urges Congress to Strengthen Medical Device Safety
FDA Issues Draft Regulatory Guidance on New Breast Cancer Drug Trials Design
House Approves FDA Funding Bill to Reduce Drug Shortages
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
